Necrotizing Fasciitis is rare but serious bacterial infection commonly known as flesh eating disease which affects the tissue beneath the skin and surrounding organs and muscles.
This report contains market size and forecasts of Necrotizing Fasciitis Drug in Global, including the following market information:
Global Necrotizing Fasciitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Necrotizing Fasciitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aminoglycoside Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Necrotizing Fasciitis Drug include GlaxoSmithKline, Pfizer, Bristol-Myers Squibb, Merck, Abbott, Teva, WOCKHARDT, Atox Bio and Basilea Pharmaceutica and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Necrotizing Fasciitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Necrotizing Fasciitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Necrotizing Fasciitis Drug Market Segment Percentages, by Type, 2021 (%)
Aminoglycoside
Metronidazole
Clindamycin
Fluoroconazoles
Others
Global Necrotizing Fasciitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Necrotizing Fasciitis Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharnacies
Retail Pharmacies
Global Necrotizing Fasciitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Necrotizing Fasciitis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Necrotizing Fasciitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Necrotizing Fasciitis Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
Bristol-Myers Squibb
Merck
Abbott
Teva
WOCKHARDT
Atox Bio
Basilea Pharmaceutica
MELINTA THERAPEUTICS